Outsourcing

Feb 02, 2016
Pharmaceutical Technology
Heightened global uncertainty could slow bio/pharma development activity.
Feb 01, 2016
Pharmaceutical Technology
Today’s analytical laboratory equipment reflects the realities of downsizing, outsourcing, and the need for speed.
Feb 01, 2016
Pharmaceutical Technology
Aging populations and increased access to healthcare translates into opportunities for biopharmaceutical companies.
Feb 01, 2016
Pharmaceutical Technology
Despite the move to more strategic partnerships, research shows that tactical outsourcing is still alive and well.
Feb 01, 2016
Pharmaceutical Technology
Only half of new drugs make it past Phase III. Adopting best practices and collaborating more closely with contract research organizations can help ensure success.
Feb 01, 2016
Pharmaceutical Technology
For successful partnerships, it’s important to take a long-term view, focus on simple designs, and address potential payer concerns up front.
Feb 01, 2016
Pharmaceutical Technology
Outsourcing lab analysis offers savings, while “workhorse” techniques can improve the efficiency of such core operations as stability testing.
Feb 01, 2016
Pharmaceutical Technology
Transparent communications, both qualitative and quantitative data, and a clear understanding of each other’s needs are keys to collaborating on better product quality.
Feb 01, 2016
Pharmaceutical Technology
Mergers and acquisitions have changed the shape of the contract services market as big players seek to build full-service capabilities.
Feb 01, 2016
Pharmaceutical Technology
Steven Denham, director of biostatistics at MPI Research, discusses the impact the Standard for Exchange of Nonclinical Data may have on the pharmaceutical industry.
lorem ipsum